FDA Adverse Event Injury Summary report: N

STELLANT DUAL CT INJECTOR

MDR report key: 18041335 · Received October 31, 2023

Report

Report Number
2520313-2023-00028
Event Type
Injury
Date Received
October 31, 2023
Date of Event
October 3, 2023
Report Date
September 23, 2024
Manufacturer
BAYER MEDICAL CARE INC.
Product Code
DXT
UDI-DI
00616258020860
PMA / PMN Number
K082905
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A SYSTEM SERVICE CHECK OF THE MEDRAD® STELLANT CT INJECTION SYSTEM (SERIAL NUMBER (B)(6)) HAS BEEN SCHEDULED. THE DISPOSABLE KIT IN USE DURING THE EVENT IS UNAVAILABLE AND DISPOSABLE INFORMATION IS UNKNOWN. THE SITE CONTINUES TO USE THE MEDRAD® STELLANT CT INJECTION SYSTEM AFTER THE REPORTED EVENT WITH NO FURTHER ISSUES REPORTED. THIS INVESTIGATION REMAINS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A FOLLOW-UP REPORT WILL BE SUBMITTED. THIS INFORMATION DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, THE COMPANY, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A REPORTABLE EVENT.

Additional Manufacturer Narrative · 0

A SYSTEM SERVICE CHECK OF THE MEDRAD® STELLANT CT INJECTION SYSTEM (SERIAL NUMBER (B)(6)) WAS COMPLETED ON NOVEMBER 21, 2023 WHICH CONFIRMED THE INJECTOR WAS PERFORMING WITHIN BAYER SPECIFICATIONS. THE DISPOSABLE KIT IN USE DURING THE EVENT IS UNAVAILABLE AND DISPOSABLE INFORMATION IS UNKNOWN. AN OFFER OF ADDITIONAL CLINICAL APPLICATIONS TRAINING HAS BEEN MADE TO THE CUSTOMER AND WAS DECLINED. THE SITE CONTINUES TO USE THE MEDRAD® STELLANT CT INJECTION SYSTEM AFTER THE REPORTED EVENT WITH NO FURTHER ISSUES REPORTED. THE MEDRAD® STELLANT CT INJECTION SYSTEM OPERATION MANUAL CAUTIONS THE USER AS FOLLOWS: WARNING: AIR EMBOLIZATION CAN CAUSE DEATH OR SERIOUS INJURY TO THE PATIENT. DO NOT CONNECT A PATIENT TO THE INJECTOR UNTIL ALL TRAPPED AIR HAS BEEN CLEARED FROM THE SYRINGE AND FLUID PATH. THIS INFORMATION DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, THE COMPANY, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A REPORTABLE EVENT.

Additional Manufacturer Narrative · 0

A SYSTEM SERVICE CHECK OF THE MEDRAD® STELLANT CT INJECTION SYSTEM (SERIAL NUMBER (B)(6)) HAS BEEN SCHEDULED AND WE ARE AWAITING THE RESULTS. THE DISPOSABLE KIT IN USE DURING THE EVENT IS UNAVAILABLE AND DISPOSABLE INFORMATION IS UNKNOWN. THE SITE CONTINUES TO USE THE MEDRAD® STELLANT CT INJECTION SYSTEM AFTER THE REPORTED EVENT WITH NO FURTHER ISSUES REPORTED. THIS INVESTIGATION REMAINS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A FOLLOW-UP REPORT WILL BE SUBMITTED. THIS INFORMATION DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, THE COMPANY, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A REPORTABLE EVENT.

Additional Manufacturer Narrative · 0

UDI RELATED DATA QUALITY UPDATES ONLY. CORRECTION: FOR UDI DATA DISCREPANCY/MISMATCH ON PREVIOUSLY SUBMITTED MDR AND TO ENSURE THE DEVICE IDENTIFICATION DATA IS IN ALIGNMENT WITH GUDID.

Description of Event or Problem · 0

BAYER MEDICAL CARE INC. WAS INFORMED OF AN ALLEGED AIR INJECTION WHILE A PATIENT WAS CONNECTED TO A MEDRAD® STELLANT CT INJECTION SYSTEM (SN (B)(6)). ALTHOUGH THE PATIENT WAS ASYMPTOMATIC THROUGHOUT THE EXAMINATION, THE PATIENT WAS SUBSEQUENTLY HOSPITALIZED FOR OBSERVATION AND HAS SINCE RECOVERED.

Description of Event or Problem · 0

BAYER MEDICAL CARE INC. WAS INFORMED OF AN ALLEGED AIR INJECTION WHILE A PATIENT WAS CONNECTED TO A MEDRAD® STELLANT CT INJECTION SYSTEM (SN (B)(6)). ALTHOUGH THE PATIENT WAS ASYMPTOMATIC THROUGHOUT THE EXAMINATION, THE PATIENT WAS SUBSEQUENTLY HOSPITALIZED FOR OBSERVATION AND HAS SINCE RECOVERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2032703 STELLANT DUAL CT INJECTOR CT INJECTION SYSTEM DXT BAYER MEDICAL CARE INC. 85937286 00616258020860

Patients

Seq Age Sex Outcome Treatment
1 88 YR Male Other